keratoconjunctivitis sicca

(redirected from Restasis)
Also found in: Dictionary.

keratoconjunctivitis

 [ker″ah-to-kon-junk″tĭ-vi´tis]
inflammation of the cornea and conjunctiva.
epidemic keratoconjunctivitis a highly infectious form, commonly with regional lymph node involvement, occurring in epidemics; an adenovirus has been repeatedly isolated from affected patients.
phlyctenular keratoconjunctivitis a form marked by formation of a phlyctenule (small lesion) at the corneal limbus.
keratoconjunctivitis sic´ca a condition marked by hyperemia of the conjunctiva, thickening and drying of the corneal epithelium, and itching and burning of the eye. Called also dry eye.

ker·a·to·con·junc·ti·vi·tis sic·ca

keratoconjunctivitis associated with decreased tears.
See also: Sjögren syndrome.
Dryness of eyes, often due to decreased tear secretion, which occurs in Sjögren syndrome, autoimmune disorders—systemic lupus, rheumatoid arthritis, scleroderma, sarcoidosis—amyloidosis, hypothyroidism, vitamin A deficiency, and in periorbital lymphoproliferative disorders

ker·a·to·con·junc·ti·vi·tis sic·ca

(ker'ă-tō-kŏn-jŭngk'ti-vī'tis sik'ă)
A chronic mucopurulent conjunctivitis, sometimes leading to corneal ulceration and scarring, due to deficit of the aqueous component of tears.
Synonym(s): dry eye syndrome.

keratoconjunctivitis sicca

Dry eye. A state of inadequate wetting and lubrication of the cornea as a result of defective tear production. This results from damage to the tear glands by the same AUTOIMMUNE DISEASE process that causes RHEUMATOID ARTHRITIS, SJOGREN'S SYNDROME, systemic lupus erythematosus and other related conditions. Dry eye is common in all these disorders. There is constant discomfort, foreign-body sensation and sometimes pain and the condition may progress to infection and ulceration of the cornea. Treatment is by the regular use of artificial tears.

ker·a·to·con·junc·ti·vi·tis sic·ca

(ker'ă-tō-kŏn-jŭngk'ti-vī'tis sik'ă)
A chronic mucopurulent conjunctivitis, sometimes leading to corneal ulceration and scarring.
Synonym(s): dry eye syndrome.
References in periodicals archive ?
Background: In 2017, Allergan sold the patents to its dry-eye medication Restasis to the St.
At the time that Allergan assigned the Restasis patents to the St.
Restasis Exclusivity to End: Restasis, treatment for chronic dry eye, accounts for roughly 8% of total firm sales, and generic competition will likely enter the market before the end of 2019.
Dublin, Ireland-based Allergan's Restasis in a preservative-free dispenser replaces single-use vials and reportedly represents the first FDA-approved multi-dose delivery system to handle prescription eye treatment formulations without preservatives.
Topical cyclosporine A 0.05% (Restasis) may also be effective for treating LASIK-induced dryness, inflammation, and neurotrophic epitheliopathy.
Observing a slow improvement in the epithelial defect and corneal infiltrates after 3 days, autologous serum eye drops (20% diluted with 0.9% sterile saline) four times daily and topical cyclosporine ophthalmic emulsion 0.05% (Restasis ([R])) eye drops four times daily were added to the initial therapy and punctal occlusion was performed using silicone plugs (Punctal Plug F, FCI Ophthalmics).
M2 EQUITYBITES-March 23, 2017-Allergan unveils RESTASIS MULTIDOSE preservative free prescription eye drop in multidose bottle in the US
Allergan, the company behind Botox, Juvederm, Restasis and other pharmaceutical products, received over $58 million in state incentives as part of the Grow New Jersey program, and worked with the mayor of Madison, Robert Conley, and Ray Codey Borough Administrator, to allow for an above grade parking garage for the facility.
Ocuvite supplements are advertised on local radio and Restasis dry eye drops (not yet available in the UK) are convincingly advertised on TV, as are many prescription-only medicines.
The Botox maker also reported (http://www.allergan.com/news/news/thomson-reuters/allergan-reports-strong-first-quarter-2016-continu) a 48 percent rise in quarterly revenue , led by a strong performance by its branded drugs business, which includes Botox and the eye drug Restasis.
(1-3) In another trial, vitamin A eyedrops were of similar efficacy to 0.05% cyclosporine eyedrops (Restasis) In improving tear production, blurred vision, and goblet cell density.
There are no reports on the use of cyclosporine (Restasis) eye drops in human pregnancy or during breastfeeding.